House Re­pub­li­cans mount a suc­cess­ful come­back cam­paign for right-to-try bill

House Re­pub­li­cans mount­ed a suc­cess­ful come­back ef­fort last night to pass a con­tro­ver­sial right-to-try bill giv­ing con­sumers the op­por­tu­ni­ty to ask for ac­cess to ex­per­i­men­tal meds with­out FDA au­tho­riza­tion. The bill now heads to the Sen­ate, which has al­ready passed sim­i­lar leg­is­la­tion and is ex­pect­ed to steer this to the pres­i­dent’s of­fice soon.

Pres­i­dent Don­ald Trump has al­so voiced his en­thu­si­as­tic sup­port, so chances are high that the leg­is­la­tion will soon be­come law.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Venture & Research Associate

Alexandria Real Estate Equities

San Francisco, CA, USA